| Literature DB >> 27602182 |
Benjamin J Schofield1, Adam Skarshewski2, Nancy Lachner2, Diane Ouwerkerk3, Athol V Klieve4, Peter Dart1, Philip Hugenholtz2.
Abstract
Bacillus amyloliquefaciens H57 is a bacterium isolated from lucerne for its ability to prevent feed spoilage. Further interest developed when ruminants fed with H57-inoculated hay showed increased weight gain and nitrogen retention relative to controls, suggesting a probiotic effect. The near complete genome of H57 is ~3.96 Mb comprising 16 contigs. Within the genome there are 3,836 protein coding genes, an estimated sixteen rRNA genes and 69 tRNA genes. H57 has the potential to synthesise four different lipopeptides and four polyketide compounds, which are known antimicrobials. This antimicrobial capacity may facilitate the observed probiotic effect.Entities:
Keywords: Antimicrobials; Bacillus amyloliquefaciens; Illumina; Probiotic
Year: 2016 PMID: 27602182 PMCID: PMC5012032 DOI: 10.1186/s40793-016-0189-z
Source DB: PubMed Journal: Stand Genomic Sci ISSN: 1944-3277
Fig. 1Maximum likelihood tree showing the alignment of H57 with other Bacillus genomes. Alignment was performed using HMMER [8] whilst maximum likelihood was inferred using FastTree version 2.7.7 [32]. The inferred tree was visualised using ARB version 6.0.2 [33]. Bar: 0.1 substitutions per nucleotide position
Fig. 2Cellular and colony morphology of B. amyloliquefaciens H57. a Vegetative H57 cells at 1000x magnification captured with a Nikon DS-Ri1 camera attached to a Nikon Eclipse 80i microscope under phase contrast. b H57 spores at 1000x magnification captured with a Leica DFC 500 camera attached to a Leica DM5500B compound microscope with Nomarski differential interference contrast. c Pure culture of H57 grown on nutrient agar plate. d Electron microscope image of a vegetative H57 cell showing numerous peritrichous flagella, negatively stained with phosphotungstic acid
Classification and general features of Bacillus amyloliquefaciens strain H57 [10]
| MIGS ID | Property | Term | Evidence codea |
|---|---|---|---|
| Classification | Domain | TAS [ | |
| Phylum | TAS [ | ||
| Class | TAS [ | ||
| Order | TAS [ | ||
| Family | TAS [ | ||
| Genus | TAS [ | ||
| Species | TAS [ | ||
| Strain: H57 | |||
| Gram stain | Positive | IDA | |
| Cell shape | Rod/chains | IDA | |
| Motility | Motile | IDA | |
| Sporulation | Sporulating | IDA | |
| Temperature range | Mesophilic | IDA | |
| Optimum temperature | 29 °C | IDA | |
| pH range; Optimum | 5-9; 7 | IDA | |
| Carbon source | Glucose, fructose, mannitol, sucrose, trehalose | IDA | |
| MIGS-6 | Habitat | Leaves of | TAS [ |
| MIGS-6.3 | Salinity | Up to 6 % (w/v) | IDA |
| MIGS-22 | Oxygen requirement | Aerobe | IDA |
| MIGS-15 | Biotic relationship | Symbiotic (beneficial) | TAS [ |
| MIGS-14 | Pathogenicity | Non-pathogen | NAS |
| MIGS-4 | Geographic location | Gatton, QLD, Australia | IDA |
| MIGS-5 | Sample collection | 2001 | IDA |
| MIGS-4.1 | Latitude | 27° 32' 24'' S | IDA |
| MIGS-4.2 | Longitude | 152° 20' 24'' E | IDA |
| MIGS-4.4 | Altitude | 89 m | IDA |
a Evidence codes - IDA Inferred from Direct Assay, TAS Traceable Author Statement (i.e., a direct report exists in the literature), NAS Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [48]
Project information
| MIGS ID | Property | Term |
|---|---|---|
| MIGS 31 | Finishing quality | Draft |
| MIGS 28 | Libraries used | Illumina paired end library (256 bp insert size) |
| MIGS 29 | Sequencing platforms | Illumina MiSeq |
| MIGS 31.2 | Fold coverage | 49× |
| MIGS 30 | Assemblers | Spades 3.0.0. |
| MIGS 32 | Gene calling method | PROKKA |
| Locus tag | Ga0082361 | |
| Genbank ID | LMUC00000000 | |
| GenBank Date of Release | 04/04/2016 | |
| GOLD ID | Ga0082361 | |
| BIOPROJECT | PRJNA300579 | |
| MIGS 13 | Source material identifier |
|
| Project relevance | Probiotic, Agriculture |
Genome statistics
| Attribute | Value | % of Total |
|---|---|---|
| Genome size (bp) | 3,958,833 | 100.00 |
| DNA coding (bp) | 3,549,557 | 89.66 |
| DNA G + C (bp) | 1,837,549 | 46.42 |
| DNA scaffolds | 16 | 100.00 |
| Total genes | 3,945 | 100.00 |
| Protein coding genes | 3,836 | 97.24 |
| RNA genes | 109 | 2.76 |
| Pseudo genes | 0 | 0.00 |
| Genes with internal clusters | 387 | 9.81 |
| Genes with function prediction | 3,182 | 80.66 |
| Genes assigned to COGs | 2,754 | 69.81 |
| Genes with Pfam domains | 3,364 | 85.27 |
| Genes with signal peptides | 191 | 4.84 |
| Genes with transmembrane helices | 1,046 | 26.51 |
| CRISPR repeats | 0 | 0.00 |
Number of genes associated with general COG functional categories
| Code | Value | %agea | Description |
|---|---|---|---|
| J | 136 | 3.48 | Translation, ribosomal structure and biogenesis |
| A | 0 | 0.00 | RNA processing and modification |
| K | 89 | 2.23 | Transcription |
| L | 95 | 2.43 | Replication, recombination and repair |
| B | 1 | 0.03 | Chromatin structure and dynamics |
| D | 22 | 0.56 | Cell cycle control, Cell division, chromosome partitioning |
| V | 17 | 0.44 | Defence mechanisms |
| T | 58 | 1.48 | Signal transduction mechanisms |
| M | 97 | 2.48 | Cell wall/membrane biogenesis |
| N | 40 | 1.02 | Cell motility |
| U | 37 | 0.95 | Intracellular trafficking and secretion |
| O | 64 | 1.64 | Posttranslational modification, protein turnover, chaperones |
| C | 92 | 2.35 | Energy production and conversion |
| G | 109 | 2.79 | Carbohydrate transport and metabolism |
| E | 160 | 4.09 | Amino acid transport and metabolism |
| F | 62 | 1.59 | Nucleotide transport and metabolism |
| H | 93 | 2.38 | Coenzyme transport and metabolism |
| I | 53 | 1.36 | Lipid transport and metabolism |
| P | 93 | 2.38 | Inorganic ion transport and metabolism |
| Q | 30 | 0.77 | Secondary metabolites biosynthesis, transport and catabolism |
| R | 203 | 5.19 | General function prediction only |
| S | 238 | 6.09 | Function unknown |
| - | 2169 | 55.49 | Not in COGs |
aThe total is based on the total number of protein coding genes in the genome
Carbohydrate activated enzyme profile of glycoside hydrolases in H57
| Family | Known activity | %a |
|---|---|---|
| GH16 | Xyloglucan, keratan-sulfate, endo-1,4-β-galactosidase, endo-1,3- β-glucanase, and others | 2.5 |
| GH4 | Maltose-6-phosphate glucosidase, α-glucosidase, α-galactosidase, and others | 7.5 |
| GH5 | Chitosanase, β-mannosidase, cellulase, glucan 1,3-β-glucosidase, and others | 2.5 |
| GH13 | α-amylase, pullulanase, cyclomaltodextrin glucanotransferase and others | 10 |
| GH11 | Xylanase | 2.5 |
| GH23 | Lysozyme type G and peptidoglycan lyase | 2.5 |
| GH3 | β-glucosidase, xylan 1,4-β-xylosidase, β-N-acetylhexosaminidase, and others | 2.5 |
| GH126 | Other | 2.5 |
| GH18 | Chitinase, endo-β-N-acetylglucosaminidase, and others | 7.5 |
| GH26 | β-mannanase and β-1,3-xylanase | 2.5 |
| GH53 | Endo-β-1,4-galactanase | 2.5 |
| GH51 | α-L-arabinofuranosidase and endoglucanase | 5 |
| GH1 | β-glucosidase, β-galactosidase, β-mannosidase, and others | 12.5 |
| GH73 | Peptidoglycan hydrolase with endo-β-N-acetylglucosaminidase specificity | 5 |
| GH30 | Glucosylceramidase, β-1,6-glucanase, β-xylosidase | 5 |
| GH32 | Endo-inulinase, endo-levanase, exo-inulinase, and others | 7.5 |
| GH46 | Chitosanase | 2.5 |
| GH109 | α-N-acetylgalactosaminidase | 5 |
| GH43 | Arabinases and xylosidases | 10 |
| GH68 | Levansucrase, β-fructofuranosidase and inulosucrase | 2.5 |
| Total GH hits: | 40 | |
| Total ORFs: | 3,828 | |
| % GH ORFs: | 1.04 |
aPercentage of total GH hits